AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (2 MB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Original Article | Open Access

Differential Transcriptome Analysis of Lung Squamous Cell Carcinoma Under Different RUNX3 Expression Patterns

Weibin Liu1 , Xiaobin Zheng2, Jianqing Zheng3, Yujie Deng4,5, Bifen Huang6, Weijin Xiao7, Jiarong Zhang1, Xuejin Zheng8, Xinlong Zheng9, Gen Lin2( ), Xiaohui Chen1,8 ( )
Department of Thoracic Surgery, NHC Key Laboratory of Cancer Metabolism, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China
Beijing Chest Hospital Cancer Centre, Capital Medical University, Beijing, China
Department of Radiation Oncology, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, China
Department of Medical Oncology, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China
Department of Medical Oncology, Fuzhou Hospital of Chinese Medicine Affiliated to Fujian University of Chinese Medicine, Fuzhou, China
Department of Obstetrics and Gynecology, People’s Hospital Affiliated of Quanzhou Medical College, Quanzhou, China
Department of Pathology, NHC Key Laboratory of Cancer Metabolism, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China
Interdisciplinary Institute of Medical Engineering of Fuzhou University, Fuzhou, China
Department of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China

Weibin Liu, Xiaobin Zheng and Jianqing Zheng contributed equally to this work.

Show Author Information

Abstract

Background

Runt‐related transcription factor 3 (RUNX3) functions as a tumor suppressor gene in numerous cancer types, including non‐small cell lung cancer, with its hypermethylation status predicting worse patient prognosis. However, any discrepancy in gene expression profiles in lung squamous cell carcinoma (LUSC) patients with different RUNX3 expression patterns remains unclear. In this study, RNA sequencing analysis was used to examine the transcriptomic differences in LUSC samples depending on their RUNX3 expression status.

Methods

Immunohistochemistry staining was used to determine the RUNX3 protein expression patterns in tumor samples. Tumor RNA was extracted from 63 LUSC cases and underwent RNA sequencing. Read counts were analyzed using Spearman's correlation, limma differential expression with Benjamini‐Hochberg false discovery rate (BH‐FDR) control, and gene set variation analysis (GSVA).

Results

In our LUSC cohort, 31 (49.21%) patients were classified as RUNX3_Positive (RUNX3_Pos) and 32 (50.79%) were classified as RUNX3_Negative. RUNX3 mRNA expression levels were significantly higher in the RUNX3_Pos group. Using limma with BH correction, no genes passed the BH‐FDR < 0.05 threshold between the groups, suggesting subtle gene‐level differences. Therefore, we reported an exploratory nominal gene list (p < 0.05 and |log2 fold‐change| > 1; 131 upregulated and 57 downregulated) for hypothesis generation only. Spearman's correlation identified 5047 positively and 25 negatively correlated mRNAs with RUNX3. GSVA suggested exploratory pathway activity patterns, with 57 pathways showing nominally higher and nine pathways showing nominally lower GSVA scores in RUNX3_Pos's tumors.

Conclusions

The RUNX3‐defined groups showed no BH‐FDR‐significant differentially expressed genes, but exhibited exploratory, nominal pathway activity patterns. These results generate testable hypotheses on RUNX3‐related biological programs in LUSC for future validation.

Graphical Abstract

RUNX3 status in lung squamous cell carcinoma (LUSC) is associated with subtle gene‐level differences but reveals exploratory pathway‐level patterns, including epithelial differentiation, extracellular matrix remodeling, and hypoxia‐related programs. These findings generate testable hypotheses for RUNX3's biological role in LUSC. BH‐FDR, Benjamini‐Hochberg false discovery rate; DEA, differential expression analysis; DEG, differentially expressed gene; GSVA, gene set variation analysis; IHC, immunohistochemistry; RUNX3, runt‐related transcription factor 3; RUNX3_Neg, RUNX3_Negative; RUNX3_Pos, RUNX3_Positive.

Electronic Supplementary Material

Download File(s)
med-4-3-373_ESM.xlsx (774.9 KB)

References

【1】
【1】
 
 
Medicine Advances
Pages 373-382

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Close
Close
Cite this article:
Liu W, Zheng X, Zheng J, et al. Differential Transcriptome Analysis of Lung Squamous Cell Carcinoma Under Different RUNX3 Expression Patterns. Medicine Advances, 2026, 4(3): 373-382. https://doi.org/10.1002/med4.70077

9

Views

0

Downloads

0

Crossref

Received: 02 November 2025
Revised: 28 January 2026
Accepted: 01 April 2026
Published: 15 August 2026
© 2026 The Author(s). Tsinghua University Press.

This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.